Clinical Trial Phases

Definition

The sequential stages of human testing required before a new drug or medical device can receive regulatory approval. Phase I assesses safety in a small group, Phase II evaluates efficacy and dosing, Phase III confirms effectiveness in large populations, and Phase IV involves post-market surveillance. Each successive phase reduces development risk and increases the asset's fair value.

Related Terms

Called Capital Cap Table (Capitalisation Table) Capital Call Capital Deepening Capital Expenditure (CapEx)

Put this knowledge to work

Use Opagio's free tools to measure and grow the intangible assets that drive your business value.